Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kitabgi

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Neuroscience|May 30, 2009
Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine releaseA Guyon, D Skrzydelski, I De Giry, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 31, 1998
Identification of the receptor subtype involved in the analgesic effect of neurotensinI Dubuc, P Sarret, C Labbé-Jullié, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonistD Gully, B Labeeuw, R Boigegrain, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Neuroscience|May 30, 2009
Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine releaseA Guyon, D Skrzydelski, I De Giry, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 31, 1998
Identification of the receptor subtype involved in the analgesic effect of neurotensinI Dubuc, P Sarret, C Labbé-Jullié, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonistD Gully, B Labeeuw, R Boigegrain, et al.
Pageof 14